CNSYCerenome Inc. Common Stock
3.070USD+2.33%Mkt Cap: 23.30M $P/E: 1.053d ago
Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obi…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap23.30M $
Enterprise Value10.94M $
Revenue (TTM)5.18M $
Gross Profit-4.31M $
Net Income (TTM)-22.39M $
Revenue/Share1.120 USD
Last Price3.070 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)1.05
P/E (Forward)-1.25
PEG2.45
EV/EBITDA-0.59
EV/Revenue2.11
P/S4.39
P/B4.17
EPS (TTM)2.76
EPS (Forward)-2.40
52W Range
2.9001% of range23.50
52W High23.50 USD
52W Low2.900 USD
Profitability
Gross Margin-83.09%
Oper. Margin-692.51%
EBITDA Margin0.00%
Profit Margin-230.24%
ROE-560.21%
ROA-137.13%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.77M $
CapEx (TTM)67.00K $
FCF Margin-291.55%
FCF Yield-64.84%
Net Debt-14.39M $
Net Debt/EBITDA0.78
Balance Sheet
Debt/Equity0.21
Current Ratio2.27
Quick Ratio2.07
Book Value/Sh0.7200 USD
Cash/Share2.196 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateApr 2, 2026
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)36.00 USD
Upside (mean)+1072.6%
Target Range12.00 USD – 57.00 USD
$12.00+1072.6% to mean$57.00
# Analysts4
Ownership
Shares Out.7.59M
Float6.46M
Insiders1.84%
Institutions16.88%
Short Interest
Short Ratio3.0d
Short % Float10.35%
Short % Out.10.30%
Shares Short709.38K
Short (prev mo.)1.12M
Technical
SMA 503.982 (-22.9%)
SMA 2007.622 (-59.7%)
Beta1.42
S&P 52W Chg18.16%
Avg Vol (30d)106.94K
Avg Vol (10d)88.42K
Technical Indicators
RSI (14)30.3
MACD-0.2431
MACD Signal-0.1877
MACD Hist.-0.0554
BB Upper4.219 USD
BB Middle3.638 USD
BB Lower3.057 USD
BB Width31.92%
ATR (14)0.2875 USD
Vol Ratio (20d)1.30x